Abstract
Purpose
The evaluation of the short-term effect of topically applied coenzyme Q10 (CoQ10) on retina and choroid in Alzheimer’s disease (AD) was aimed in this study.
Methods
Randomized controlled study included a total of 93 patients, 62 of whom with AD. Thirty (32.3%) AD patients received treatment (Group 1), 32 (34.4%) AD patients observed without treatment (Group 2), and Group 3 included 31 (33.3%) healthy controls (HC). Neurological and ophthalmological examinations including optical coherence tomography (OCT) were executed.
Results
Retinal nerve fiber layer (RNFL) thickness in all quadrants increased following CoQ10 treatment in Group 1; however significant rise yielded in average and temporal quadrant RNFL thickness. Average and superonasal sector ganglion cell-inner plexiform layer (GCIPL) thickness increased significantly following CoQ10 treatment. The correlation analysis between difference in pre- and posttreatment OCT values in Group 1 revealed that rise in average RNFL thickness was inversely correlated with duration of the disease and rise in average GCIPL thickness and superonasal sector thickness was inversely correlated with severity of the disease.
Conclusion
Short-term topical CoQ10 resulted in improvement in AD related retinal ganglion cell (RGC) loss which may reflect the salvage of some RGCs in the reversible transitional phase. More bioavailability through intravitreal route of administration and longer duration of effect with sustained release forms may possibly help enhalting the RGC loss, especially incipience of neurodegenerative diseases.
Similar content being viewed by others
References
Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M et al (2005) Alzheimer's disease international. Global prevalence of dementia: a Delphi consensus study. Lancet 366:2112–2117
Perl DP (2010) Neuropathology of Alzheimer’s disease. Mt Sinai J Med 77:32–42
Jack CR, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC et al (2011) Introduction to the recommendations from the national institute on aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement J Alzheimer’s Assoc 7:257–262
McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH (2011) The diagnosis of dementia due to Alzheimer's disease: recommendations from the national institute on aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:263–269
Cronin-Golomb A, Corkin S, Rizzo JF, Cohen J, Growdon JH, Banks KS (1991) Visual dysfunction in Alzheimer’s disease: relation to normal aging. Ann Neurol 29:41–52
Hinton DR, Sadun AA, Blanks JC, Miller CA (1986) Optic nerve degeneration in Alzheimer’s disease. N Engl J Med 315:485–487
La Morgia C, Ross-Cisneros FN, Koronyo Y, Hannibal J, Gallassi R, Cantalupo G et al (2016) Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann Neurol 79:90–109
Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL (2007) Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci 48:2285–2289
Kalaria RN (2000) The role of cerebral ischemia in Alzheimer’s disease neurobiology of aging. Neurobiol Aging 21:321–330
Bulut M, Yaman A, Erol MK, Kurtuluş F, Toslak D, Doğan B (2016) Choroidal thickness in patients with mild cognitive impairment and Alzheimer's type dementia. J Ophthalmol. https://doi.org/10.1155/2016/2898704.
Cunha JP, Proença R, Dias-Santos A, Melancia D, Almeida R, Águas H et al (2017) Choroidal thinning: Alzheimer's disease and aging. Alzheimers Dement 30:11–17
Wang X, Wang W, Li L, Perry G, Lee HG, Zhu X (2014) Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. Biochim Biophys Acta 1842:1240–1247
Lee J, Boo JH, Ryu H (2009) The failure of mitochondria leads to neurodegeneration: do mitochondria need a jump start? Adv Drug Deliv Rev 61:1316–1323
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer’s disease. Neurology 34:939–944
He XF, Liu YT, Peng C, Zhang F, Zhuang S, Zhang JS (2012) Optical coherence tomography assessed retinal nerve fiber layer thickness in patients with Alzheimer’s disease: a meta-analysis. Int J Ophthalmol 5:401–405
den Haan J, Verbraak FD, Visser PJ, Bouwman FH (2017) Retinal thickness in Alzheimer’s disease: a systematic review and meta-analysis. Alzheimers Dement 6:162–170
Iseri PK, Altinas O, Tokay T, Yuksel N (2006) Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 26:18–24
Cunha LP, Lopes LC, Costa-Cunha LV, Costa CF, Pires LA, Almeida AL et al (2016) Macular thickness measurements with frequency domain-OCT for quantification of retinal neural loss and its correlation with cognitive impairment in Alzheimer’s disease. PLoS One. https://doi.org/10.1371/journal.pone.0153830
Kromer R, Serbecic N, Hausner L, Froelich L, Aboul-Enein F, Beutelspacher SC (2014) Detection of retinal nerve fiber layer defects in Alzheimer’s disease using SD-OCT. Front Psychiatry 5:22
Kirbas S, Turkyilmaz K, Anlar O, Tufekci A, Durmus M (2013) Retinal nerve fiber layer thickness in patients with Alzheimer disease. J Neuroophthalmol 33:58–61
Oktem EO, Derle E, Kibaroglu S, Oktem C, Akkoyun I, Can U (2015) The relationship between the degree of cognitive impairment and retinal nerve fiber layer thickness. Neurol Sci 36:1141–1146
Cunha JP, Moura-Coelho N, Proença RP, Dias-Santos A, Ferreira J, Louro C et al (2016) Alzheimer’s disease: a review of its visual system neuropathology. Optical coherence tomography—a potential role as a study tool in vivo. Graefes Arch Clin Exp Ophthalmol 254:2079–2092
Cunha LP, Almeida AL, Costa-Cunha LV, Costa CF, Monteiro ML (2016) The role of optical coherence tomography in Alzheimer’s disease. Int J Retina Vitreous 2:24
Cheung CY, Ong YT, Hilal S, Ikram MK, Low S, Ong YL et al (2015) Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis 45:45–56
Martin EG, Bambo MP, Marquesetal ML (2016) Ganglion cell layer measurements correlate with disease severity in patients with Alzheimer’s disease. Acta Ophthalmol 94:454–459
Williams MA, Mcgowan AJ, Cardwell CR, Cheung CY, Craig D, Passmore P (2015) Retinal microvascular network attenuation in Alzheimer's disease. Alzheimers Dement 1:229–235
Tzekov R, Mullan M (2014) Vision function abnormalities in Alzheimer disease. Surv Ophthalmol 59:414–433
Ajith TA (2013) Mitochondria: oxidative stress, dysfunction and cell death. VNT Biol Med Chem 1:21–32
Dumont M, Kipiani K, Yu F, Wille E, Katz M, Calingasan NY et al (2011) Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease. J Alzheimers Dis 27:211–223
Ishrat T, Khan MB, Hoda MN, Yousuf S, Ahmad M, Ansari MA et al (2006) Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats. Behav Brain Res 171:9–16
Qu J, Kaufman Y, Washington I (2009) Coenzyme q10 in the human retina. Invest Ophthalmol Vis Sci 50:1814–1818
Durán-Prado M, Frontiñán J, Santiago-Mora R, Peinado JR, Parrado-Fernández C, Gómez-Almagro MV et al (2014) Coenzyme Q10 protects human endothelial cells from β-amyloid uptake and oxidative stress-induced injury. PLoS One. https://doi.org/10.1371/journal.pone.0109223
Feher J, Kovacs B, Kovacs I, Schveoller M, Papale A, Balacco Gabrieli C (2015) Improvement of visual functions and fundus alterations in early age-related macular degeneration treated with a combination of acetyl-l-carnitine, n-3 fatty acids, and coenzyme Q10. Int J Ophthalmol 219:154–166
Paris V, Centofanti M, Gandolfi S, Marangoni D, Rossetti L, Tanga L et al (2014) Effects of coenzyme Q10 in conjunction with vitamin E on retinal-evoked and cortical-evoked responses in patients with open-angle glaucoma. J Glaucoma 23:391–404
Fato R, Bergamini C, Leoni S, Pinna A, Carta F, Cardascia N et al (2010) Coenzyme Q10 vitreous levels after administration of coenzyme Q10 eyedrops in patients undergoing vitrectomy. Acta Ophthalmol. https://doi.org/10.1111/j.1755-3768.2009.01632
Porciatti V, Ventura LM (2012) Retinal ganglion cell functional plasticity and optic neuropathy: a comprehensive model. J Neuroophthalmol 32:354–358
Banitt MR, Ventura LM, Feuer WJ, Savatovsky E, Luna G, Shif O et al (2013) Progressive loss of retinal ganglion cell function precedes structural loss by several years in glaucoma suspects. Invest Ophthalmol Vis Sci. https://doi.org/10.1167/iovs.12-11
Author contributions
Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work: Refika Hande Karakahya, Tuba Şaziye Özcan
Drafting the work or revising it critically for important intellectual content: Tuba Şaziye Özcan
Final approval of the version to be published: Refika Hande Karakahya, Tuba Şaziye Özcan
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict(s) of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ordu University Ethical Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Statement of informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Karakahya, R.H., Özcan, T.Ş. Salvage of the retinal ganglion cells in transition phase in Alzheimer’s disease with topical coenzyme Q10: is it possible?. Graefes Arch Clin Exp Ophthalmol 258, 411–418 (2020). https://doi.org/10.1007/s00417-019-04544-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-019-04544-3